Dynavax Initiates Large-Scale Phase 3 Trial of »
The hepatitis B surface antigen in the HEPLISAV lots being evaluated was produced in Dynavax's manufacturing facility in Düsseldorf ... View post: Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM) - PR Inside


